Search Results

9 results

  1. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 59

    An inter-laboratory comparison study focused on the determination of total NNAL in human urine

    NEWLAND K.(1); SCHERER M.(2); HECHT S.S.(3); TROUDE V.(4); PRASAD G.L.(5)
    (1) Celerion Inc., Lincoln, NE, U.S.A.; (2) ABF GmbH, Planegg, Germany; (3) University of Minnesota Cancer Center, Minneapolis, MN, U.S.A.; (4) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (5) RAI Services Company, Winston-Salem, NC, U.S.A.
    In an ongoing effort to fulfil the second objective of the CORESTA Biomarker Sub-Group, periodic inter-laboratory comparison studies have been performed to evaluate the consistency of the quantitation for various harmful or potentially harmful exposure ...
  2. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 52

    Biological test procedure for fresh generated cigarette smoke and e-cigarette aerosols under air-liquid interface (ALI) exposure in 24 and 96 multi-well plates

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    Cigarette smoke and e cigarette aerosol contain particulate matter/liquid droplets in the solid phase as well as volatile substances in the gas phase. Both fractions are of potential toxicological relevance and should be considered when assessing ...
  3. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 53

    Use of human derived cell lines to increase the biological relevance of cigarette condensate, non-tobacco materials and e-liquids testing

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    The in vitro testing strategy of tobacco products is mainly based on the testing of extracts from cigarette smoke condensates. An accepted industry wide assay battery has been developed over recent years which delivers reliable results for the ...
  4. CORESTA Congress, Berlin, 2016, Smoke Science/Product Technology Groups (Workshop), STW 02

    Implications of product testing: method variability and suitability and ratio of smoke emissions to nicotine

    INTORP M.
    (1) Reemtsma Cigarettenfabriken GmbH (an Imperial Brands PLC Company), Hamburg, Germany; (2) SEITA-Imperial Tobacco, Fleury-les-Aubrais, France
    Regulatory authorities are discussing the measurement of certain smoke constituents, and this may eventually lead to discussion of ceilings. For this purpose internationally standardised methods are required to enable the generation of reliable data. ...
  5. CORESTA Congress, Berlin, 2016, Smoke Science/Product Technology Groups, ST 19

    Smoke analysis of fine-cut tobacco (Part 3) – Physical characterisation of fine-cut smoking articles and their variability

    TEILLET B.(1); DESTRUHAUT S.(1); CHAVES L.(2)
    (1) SEITA-Imperial Tobacco, Fleury-les-Aubrais, France; (2) Reemtsma Cigarettenfabriken GmbH (an Imperial Brands PLC Company), Hamburg, Germany
    There is current regulatory interest in emissions from fine-cut tobacco. Various approaches exist for measuring emissions from fine-cut tobacco, such as ISO Standard 15592, and some countries have established their own specific methods (e.g. Canada and ...
  6. CORESTA Congress, Paris, 2006, PT 15

    Reconstituted tobacco treatment to reduce TSNA content of tobacco products - Part I: Tobacco treatment during reconstitution

    RIGOULAY C.; LE BEC L.; RAVERDY-LAMBERT D.; LE BOURVELLEC G.
    LTR Industries (SWM Intl.), Le Mans, France
    A lot of effort has been devoted since several years to reduce tobacco specific nitrosamines (TSNA) in tobacco products. Tobacco breeding, cultural and curing practices have been improved to prevent TSNA formation. The paper making reconstitution of ...
  7. CORESTA Congress, Paris, 2006, PT 16

    Reconstituted tobacco treatment to reduce TSNA content of tobacco products - Part II: Effect of the treatment on TSNA and Hoffmann analytes in mainstream smoke

    LE BEC L.; RIGOULAY C.; RAVERDY-LAMBERT D.; LE BOURVELLEC G.
    LTR Industries (SWM Intl.), Le Mans, France
    In part I, we have presented a treatment that reduces TSNA levels in tobacco during reconstitution and its effects on tobacco chemistry. The objective of this paper is to present the smoking results of the reconstituted tobacco treated to reduce the TSNA ...